People: GlaxoSmithKline PLC (GSK.L)

GSK.L on London Stock Exchange

1,749.50GBp
12:04pm EDT
Price Change (% chg)

7.50p (+0.43%)
Prev Close
1,742.00p
Open
1,743.50p
Day's High
1,750.00p
Day's Low
1,726.50p
Volume
7,816,873
Avg. Vol
7,634,310
52-wk High
1,773.00p
52-wk Low
1,314.00p

Search Stocks

Witty, Andrew 

Brief Biography

Sir Andrew Philip Witty is Chief Executive Officer, Executive Director of GlaxoSmithKline PLC. He joined GSK in 1985. He has worked in the UK, South Africa, the USA and Singapore in various senior roles. In 2003, he was appointed President of GSK Europe and joined GSK’s Corporate Executive Team. He was appointed CEO in May 2008. While in Singapore, Sir Andrew was a Board Member of the Singapore Economic Development Board and the Singapore Land Authority. In 2003 he was awarded the Public Service Medal by the Government of Singapore and in August 2012 was also awarded the Public Service Star. In the 2012 New Year Honours list, he was awarded a Knighthood for services to the economy and to the UK pharmaceutical industry. He is currently a member of the Prime Minister’s Business Advisory Group and was a board member of INSEAD Business School until January 2012. He is currently the Lead Non-Executive Board Member for the Department for Business, Innovation and Skills. He is also President of the European Federation of Pharmaceutical Industries and Associations and Chancellor of the University of Nottingham.

Basic Compensation

Total Annual Compensation, GBP Long-Term Incentive Plans, GBP All Other, GBP Fiscal Year Total, GBP
1,987,000 1,905,000 -- 3,892,000

Options Compensation

  Quantity Market Value
Excercisable -- --
Unexercisable -- --
Excercised -- --
Name Fiscal Year Total

Christopher Gent

675,000

Andrew Witty

3,892,000

Simon Dingemans

1,186,000

Moncef Slaoui

4,610,000

Deirdre Connelly

--

Roger Connor

--
As Of 30 Dec 2012
Search Stocks